Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone furoate Galenica cream versus Elocon and placebo in mild to moderate plaque psoriasis
2009-016827-72Phase 3Completed
- Sponsor
- Galenica
- Start
- Nov 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of mometasone in plaque psoriasis (3 arms), sponsored by Galenica. Primary endpoint: Total Severity Score. Started Nov 2009; status: completed.
02
Drugs
mometasone
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2009-016827-72.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016827-72.